Recombinant activated factor VII in paediatric cardiac surgery.

Intensive Care Med

Paediatric Intensive Care Unit, The Children's Hospital at Westmead, Locked Bag 4001 Westmead, NSW 2145, Sydney, Australia.

Published: April 2004

Objective: To review the use of recombinant activated factor VII in paediatric cardiac surgery.

Design: Retrospective chart review.

Setting: Paediatric intensive care unit in a stand-alone university-affiliated children's hospital.

Patients And Participants: Cardiac surgical patients who received recombinant activated factor VII (rFVIIa, NovoSeven; NovoNordisk, Copenhagen, Denmark) between June 2002 and June 2003 at The Children's Hospital at Westmead.

Results: Six children undergoing cardiac surgery received rFVIIa. Recombinant activated factor VII was administered if bleeding was excessive and persisted despite appropriate investigation and attention to haemostasis by surgical and medical staff. An intravenous dose of 180 microg/kg was given and repeated 2 h later. All of the six patients responded well to rFVIIa with achievement of haemostasis. No adverse events were noted.

Conclusions: Recombinant activated factor VII achieved haemostasis in six paediatric cardiac surgical patients. Good outcomes and no adverse events were noted in these children.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00134-003-2108-1DOI Listing

Publication Analysis

Top Keywords

recombinant activated
20
activated factor
20
factor vii
20
paediatric cardiac
12
vii paediatric
8
cardiac surgery
8
cardiac surgical
8
surgical patients
8
adverse events
8
recombinant
5

Similar Publications

Background: Liver fibrosis is caused by chronic toxic or cholestatic liver injury. Fibrosis results from the recruitment of myeloid cells into the injured liver, the release of inflammatory and fibrogenic cytokines, and the activation of myofibroblasts, which secrete extracellular matrix, mostly collagen type I. Hepatic myofibroblasts originate from liver-resident mesenchymal cells, including HSCs and bone marrow-derived CD45+ collagen type I+ expressing fibrocytes.

View Article and Find Full Text PDF

Recombinant expression and characterization of the family 5 cellulase from in BL21-CodonPlus (DE3)-RIPL.

Biochem Biophys Rep

March 2025

Institute of Biotechnology, Bioengineering and Food Systems, Advanced Engineering School, Far Eastern Federal University, Vladivostok, 690922, Russia.

B. velezensis RB. IBE29 is a chitinolytic bacterium originally isolated from agricultural soil of Vietnam.

View Article and Find Full Text PDF

Introduction: In the last decades, the recombinant tissue plasminogen activator alteplase has been the standard fibrinolytic treatment of acute myocardial infarction, pulmonary embolism, and acute ischemic stroke. An optimized version of alteplase, tenecteplase, has been developed by exchanging six amino acids to increase half-life, achieve higher fibrin selectivity and increase resistance to plasminogen activator inhibitor-1. Meanwhile, several products containing tenecteplase exist.

View Article and Find Full Text PDF

10 years of BiTE immunotherapy: an overview with a focus on pancreatic cancer.

Front Oncol

December 2024

Research Department of Haematology, UCL Cancer Institute, University College London, London, United Kingdom.

Various therapeutic strategies have been developed to treat Pancreatic Cancer (PaCa). Unfortunately, most efforts have proved unfruitful, as the poor prognosis observed in this disease has only attained little improvement in the past 40 years. Recently, deeper understanding of the immune system and its interaction with malignant tumors have allowed significant advances in immunotherapy.

View Article and Find Full Text PDF

We present a novel approach for enhancing photocatalytic efficiency by developing polyaniline (PANI) and polyindole (PIN)-coated TiO nanotubes (TNT) through a combination of chemical oxidation and hydrothermal processes. The PANI-PIN coating was systematically applied to both the internal and external surfaces of the nanotubes to enhance the photocatalytic active sites and optimize pollutant adsorption. The dual-coated structure enhances the interaction with pollutants, facilitating a more efficient degradation of 4-nitrophenol (4-NP) when exposed to visible light.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!